Kristien Van der Elst Selected Research

Leflunomide (Arava)

9/2020	Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT.
1/2020	Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristien Van der Elst Research Topics

Disease

11	Rheumatoid Arthritis 06/2021 - 01/2015
3	Pain (Aches) 01/2021 - 01/2014
2	Fatigue 01/2021 - 01/2014
1	Asthenopia (Eyestrain) 01/2021
1	Joint Diseases (Joint Disease) 03/2017

Drug/Important Bio-Agent (IBA)

9	GlucocorticoidsIBA 06/2021 - 01/2015
6	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 04/2015
2	ametantrone (HAQ)IBA 01/2021 - 01/2014
2	C-Reactive ProteinIBA 01/2021 - 03/2017
2	Leflunomide (Arava)FDA LinkGeneric 09/2020 - 01/2020
2	Antirheumatic Agents (DMARD)IBA 03/2017 - 01/2015
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020

Therapy/Procedure

3	Therapeutics 06/2021 - 01/2015
3	Remission Induction 01/2020 - 01/2015
1	Aftercare (After-Treatment) 01/2020